Redcliffe Labs appoints Ishaan Khanna as Director - Reproductive Medicine and Genetics

New Delhi, 26^thMay, 2022: Redcliffe Labs, a unit of Redcliffe Lifetech in the U.S. and India, has recently announced Ishaan Khanna as Director - Reproductive Medicine and Genetics.

Ishaan is a techno-commercial leader with over 19 years of experience in institutional and commercial healthcare businesses. He has effectively built organizations from the ground up and demonstrated success in establishing successful; diagnostic business models in India and abroad.

He started his career as scientist with assignments spanning across Australia and UK. After coming back to India he worked in Business development leadership roles in Biotech and pharma companies such as Avesthagen and Krishna Antioxidants.

His last assignment was at Lifecell where he was the CEO, Biobank and Diagnostics where he spent over a decade.

He also brought some of the key diagnostic platforms to India for the first time such as QFPCR and rapid genetic testing to support the need of sick infants and pregnant womenand building leadership in domains such as newborn screening. In his previous roles he has built pan India network of labs and efficient networks, something which he wishes to do at a much larger scale at Redcliffe.